These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18496183)

  • 1. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.
    Narayan RK; Maas AI; Marshall LF; Servadei F; Skolnick BE; Tillinger MN;
    Neurosurgery; 2008 Apr; 62(4):776-86; discussion 786-8. PubMed ID: 18496183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.
    Vincent JL; Artigas A; Petersen LC; Meyer C
    Crit Care Med; 2009 Jun; 37(6):1874-80. PubMed ID: 19384216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
    Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
    Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
    Mayer SA; Brun NC; Broderick J; Davis SM; Diringer MN; Skolnick BE; Steiner T;
    Neurocrit Care; 2006; 4(3):206-14. PubMed ID: 16757825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
    Gill R; Herbertson M; Vuylsteke A; Olsen PS; von Heymann C; Mythen M; Sellke F; Booth F; Schmidt TA
    Circulation; 2009 Jul; 120(1):21-7. PubMed ID: 19546387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study.
    Imberti R; Pietrobono L; Klersy C; Gamba G; Iotti GA; Cornara G
    Minerva Anestesiol; 2012 Feb; 78(2):168-75. PubMed ID: 21750485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
    Bartal C; Freedman J; Bowman K; Cusimano M
    J Trauma; 2007 Oct; 63(4):725-32. PubMed ID: 18089997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
    Sachs B; Delacy D; Green J; Graham RS; Ramsay J; Kreisler N; Kruse P; Khutoryansky N; Hu SS
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2285-93. PubMed ID: 17906567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
    O'Connell KA; Wood JJ; Wise RP; Lozier JN; Braun MM
    JAMA; 2006 Jan; 295(3):293-8. PubMed ID: 16418464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial.
    Al-Ajlan FS; Gladstone DJ; Song D; Thorpe KE; Swartz RH; Butcher KS; Del Campo M; Dowlatshahi D; Gensicke H; Lee GJ; Flaherty ML; Hill MD; Aviv RI; Demchuk AM;
    Stroke; 2023 Mar; 54(3):715-721. PubMed ID: 36756899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury.
    Yuan Q; Wu X; Du ZY; Sun YR; Yu J; Li ZQ; Wu XH; Mao Y; Zhou LF; Hu J
    J Crit Care; 2015 Feb; 30(1):116-20. PubMed ID: 25092615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
    Bosch J; Thabut D; Albillos A; Carbonell N; Spicak J; Massard J; D'Amico G; Lebrec D; de Franchis R; Fabricius S; Cai Y; Bendtsen F;
    Hepatology; 2008 May; 47(5):1604-14. PubMed ID: 18393319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
    Nishijima DK; Dager WE; Schrot RJ; Holmes JF
    Acad Emerg Med; 2010 Mar; 17(3):244-51. PubMed ID: 20370756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.
    Lodge JP; Jonas S; Jones RM; Olausson M; Mir-Pallardo J; Soefelt S; Garcia-Valdecasas JC; McAlister V; Mirza DF;
    Liver Transpl; 2005 Aug; 11(8):973-9. PubMed ID: 16035095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.